Consolidated Statements of Changes in Stockholder's Equity - USD ($) $ in Thousands		Total	Common Stock		Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Restricted Stock Awards Common Stock
Beginning balance (in shares) at Dec. 31, 2021	[1]		7,441,668
Beginning balance at Dec. 31, 2021		$ 100,552	$ 2		$ 632,513	$ (530,851)	$ (1,112)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock—restricted stock (in shares)	[1]							(28,387)
Compensation expense related to issued stock options and restricted stock awards		736			736
Net loss		(16,031)				(16,031)
Other comprehensive income (loss)		737					737
Ending balance (in shares) at Mar. 31, 2022	[1]		7,413,281
Ending balance at Mar. 31, 2022		$ 85,994	$ 2		633,249	(546,882)	(375)
Beginning balance (in shares) at Dec. 31, 2022		7,502,462	7,502,462	[1]
Beginning balance at Dec. 31, 2022		$ 54,179	$ 0		634,647	(581,324)	856
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock—restricted stock (in shares)	[1]							(5,324)
Compensation expense related to issued stock options and restricted stock awards		621			621
Net loss		(9,571)				(9,571)
Other comprehensive income (loss)		$ (604)					(604)
Ending balance (in shares) at Mar. 31, 2023		7,497,138	7,497,138	[1]
Ending balance at Mar. 31, 2023		$ 44,625	$ 0		$ 635,268	$ (590,895)	$ 252

[1] *Adjusted for the 1-for-25 reverse stock split